Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Imatinib mesylate-induced hyperpigmentation of the nose and palate.

Literature DB >> 25143691

Imatinib mesylate-induced hyperpigmentation of the nose and palate.

Hyo Sang Song¹, Hee Young Kang¹.

Abstract

Entities: Chemical Disease Gene Species

Year: 2014 PMID： 25143691 PMCID： PMC4135117 DOI： 10.5021/ad.2014.26.4.532

Source DB: PubMed Journal: Ann Dermatol ISSN： 1013-9087 Impact factor: 1.444

× No keyword cloud information.

5 in total

1. Imatinib mesilate inhibits melanogenesis in vitro.

Authors: M Cario-André; L Ardilouze; C Pain; Y Gauthier; F-X Mahon; A Taieb
Journal: Br J Dermatol Date: 2006-08 Impact factor: 9.302

2. Imatinib-associated hyperpigmentation, a side effect that should be recognized.

Authors: T Mcpherson; V Sherman; R Turner
Journal: J Eur Acad Dermatol Venereol Date: 2008-04-01 Impact factor: 6.166

3. Imatinib-associated hyperpigmentation of the palate in post-HSCT patient.

Authors: Renata Gonçalves Resende; Raissa Gabriela Lopes Teixeira; Fabiana de Oliveira Vasconcelos; Maria Elisa de Souza Silva; Mauro Henrique Guimarães Abreu; Ricardo Santiago Gomez
Journal: J Craniomaxillofac Surg Date: 2011-09-08 Impact factor: 2.078

4. Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: a prospective study of 54 patients.

Authors: Laurence Valeyrie; Sylvie Bastuji-Garin; Jean Revuz; Nicolas Bachot; Janine Wechsler; Patrice Berthaud; Michel Tulliez; Stéphane Giraudier
Journal: J Am Acad Dermatol Date: 2003-02 Impact factor: 11.527

5. Imatinib mesylate causes hypopigmentation in the skin.

Authors: Anne S Tsao; Hagop Kantarjian; Jorge Cortes; Susan O'Brien; Moshe Talpaz
Journal: Cancer Date: 2003-12-01 Impact factor: 6.860

5 in total

6 in total

Imatinib mesylate-induced hyperpigmentation of the nose and palate.

1. Imatinib mesilate inhibits melanogenesis in vitro.

2. Imatinib-associated hyperpigmentation, a side effect that should be recognized.

3. Imatinib-associated hyperpigmentation of the palate in post-HSCT patient.

4. Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: a prospective study of 54 patients.

5. Imatinib mesylate causes hypopigmentation in the skin.

1. Acquired Brachial Cutaneous Dyschromatosis in a Middle Aged Male.

Review 2. Pigmentary changes in patients treated with targeted anticancer agents: A systematic review and meta-analysis.

3. Mucosal pigmentation of the hard palate in a patient taking imatinib.

Review 4. Medication-Induced Oral Hyperpigmentation: A Systematic Review.

5. Hyperpigmentation of the hard palate mucosa in a patient with chronic myeloid leukaemia taking imatinib.

6. Imatinib Mesylate-Induced Acquired Dermal Melanocytosis and Acquired Bilateral Nevus of Ota-Like Macules.